Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
Chikara Komiya(Tokyo Medical and Dental University), Yoshihiro Ogawa(Kyushu University)
Cited by 229
Related Papers
Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis
|Nature Communications|2014|196
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
|Scientific Reports|2018|174
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
|Scientific Reports|2018|86
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
|Scientific Reports|2017|64
A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition
|Scientific Reports|2018|57